Retinal Microcirculation Changes in Crohn's Disease Patients under Biologics, a Potential Biomarker of Severity: A Pilot Study.

Crohn’s disease OCT angiography cardiovascular disease fundus photographs population-based study retinal vascular network vascular predicting capacity vascular prevention

Journal

Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269

Informations de publication

Date de publication:
07 Feb 2022
Historique:
received: 22 12 2021
revised: 02 02 2022
accepted: 02 02 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Crohn's disease (CD) is associated with increased cardiovascular risk and the retinal microcirculation is a reflection of the systemic microcirculation. Is the retinal microcirculation altered in relation to the severity of Crohn's disease? This cross-sectional case-controlled study was conducted in a university hospital center from November 2020 to February 2021. We prospectively included patients with moderate (biologic therapy) or severe (biologic therapy + peri-anal disease and/or digestive resection) CD and age- and sex-matched controls. Individuals with diabetes, renal disease, cardiovascular disease, ophthalmological history or poor quality images were excluded. All participants underwent OCT angiography (OCT-A) imaging (Optovue, Fremont, CA). Analysis of covariance was used. 74 CD patients (33 moderate, 41 severe) and 74 controls (66 (44.6%) men; mean (SD) age 44 (14) years) were included. Compared with the controls, the severe CD patients showed a significantly reduced mean foveal avascular zone area (

Identifiants

pubmed: 35207718
pii: jpm12020230
doi: 10.3390/jpm12020230
pmc: PMC8878992
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Med Arch. 2020 Jun;74(3):191-194
pubmed: 32801434
Am J Physiol Heart Circ Physiol. 2017 Feb 1;312(2):H201-H212
pubmed: 27923786
Am J Gastroenterol. 2011 Jan;106(1):110-9
pubmed: 20808297
JAMA. 2013 May 22;309(20):2150-8
pubmed: 23695484
Lancet. 2010 Feb 20;375(9715):657-63
pubmed: 20149425
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
PLoS One. 2018 Aug 31;13(8):e0201991
pubmed: 30169521
Gut. 2006 Jun;55(6):749-53
pubmed: 16698746
J Crohns Colitis. 2014 Jun;8(6):469-79
pubmed: 24183231
Am J Gastroenterol. 2011 Apr;106(4):741-7
pubmed: 21386828
Curr Drug Targets. 2015;16(3):181-8
pubmed: 25642719
Circulation. 2000 Aug 29;102(9):994-9
pubmed: 10961963
Ann Intensive Care. 2020 Nov 12;10(1):152
pubmed: 33184724
Invest Ophthalmol Vis Sci. 2015 May;56(5):3212-7
pubmed: 26024105
J Crohns Colitis. 2017 Jan;11(1):3-25
pubmed: 27660341
N Engl J Med. 2008 Nov 20;359(21):2195-207
pubmed: 18997196
Clin Gastroenterol Hepatol. 2014 Mar;12(3):382-93.e1: quiz e22
pubmed: 23978350
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):4299-4306
pubmed: 30372758
Lancet. 2012 Nov 3;380(9853):1590-605
pubmed: 22914295
Heart Fail Rev. 2003 Jan;8(1):71-86
pubmed: 12652161
Clin Gastroenterol Hepatol. 2008 Jan;6(1):41-5
pubmed: 18063423
Retina. 2017 Nov;37(11):2102-2111
pubmed: 27997512
Eur J Ophthalmol. 2021 Jul 27;:11206721211035626
pubmed: 34313159
Graefes Arch Clin Exp Ophthalmol. 2020 Oct;258(10):2263-2269
pubmed: 32533282
J Crohns Colitis. 2019 Feb 1;13(2):144-164
pubmed: 30137275
Int J Retina Vitreous. 2019 Aug 6;5:16
pubmed: 31406581
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5754-5763
pubmed: 29114842
J Crohns Colitis. 2020 Jan 1;14(1):4-22
pubmed: 31711158
Gut. 2020 May;69(5):852-858
pubmed: 31446428
Arq Gastroenterol. 2018 Apr-Jun;55(2):188-191
pubmed: 30043872
Mod Rheumatol. 2021 Jul;31(4):817-826
pubmed: 32997565
Front Immunol. 2018 Mar 02;9:430
pubmed: 29552019
Expert Rev Gastroenterol Hepatol. 2011 Dec;5(6):703-16
pubmed: 22017698
BMJ. 2016 Feb 25;352:i969
pubmed: 26916049
J Crohns Colitis. 2019 Mar 26;13(3):273-284
pubmed: 30137278
Gut. 2018 Jul;67(7):1261-1268
pubmed: 28647686
Rheumatology (Oxford). 2014 Jun;53(6):1108-19
pubmed: 24501245
Retina. 2018 Aug;38(8):1613-1619
pubmed: 28665869
Dev Ophthalmol. 2016;56:6-12
pubmed: 27022989
Graefes Arch Clin Exp Ophthalmol. 2019 Aug;257(8):1687-1698
pubmed: 31147842
J Crohns Colitis. 2013 Jul;7(6):451-9
pubmed: 22841134
Biochem Pharmacol. 2009 Sep 15;78(6):539-52
pubmed: 19413999
J Crohns Colitis. 2016 Mar;10(3):239-54
pubmed: 26614685
Prog Retin Eye Res. 2017 Sep;60:66-100
pubmed: 28760677

Auteurs

Eloi Debourdeau (E)

Department of Ophthalmology, Gui de Chauliac Hospital, F-34000 Montpellier, France.
Institute for Neurosciences of Montpellier INM, University Montpellier, INSERM, F-34091 Montpellier, France.

Chloé Charmard (C)

Department of Ophthalmology, Gui de Chauliac Hospital, F-34000 Montpellier, France.
Institute for Neurosciences of Montpellier INM, University Montpellier, INSERM, F-34091 Montpellier, France.

Isabelle Carriere (I)

Institute for Neurosciences of Montpellier INM, University Montpellier, INSERM, F-34091 Montpellier, France.

Julien Plat (J)

Department of Ophthalmology, Gui de Chauliac Hospital, F-34000 Montpellier, France.

Max Villain (M)

Department of Ophthalmology, Gui de Chauliac Hospital, F-34000 Montpellier, France.

Lucile Boivineau (L)

Department of Gastroenterology and Hepatology, Saint-Eloi Hospital, F-34000 Montpellier, France.

Romain Altwegg (R)

Department of Gastroenterology and Hepatology, Saint-Eloi Hospital, F-34000 Montpellier, France.

Vincent Daien (V)

Department of Ophthalmology, Gui de Chauliac Hospital, F-34000 Montpellier, France.
Institute for Neurosciences of Montpellier INM, University Montpellier, INSERM, F-34091 Montpellier, France.
The Save Sight Institute, Sydney Medical School, The University of Sydney, Sydney, NSW 2000, Australia.

Classifications MeSH